Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Irwin Bernstein
Fred Hutchinson Cancer Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Nohla Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The project will involve the evaluation of technology invented in part by Dr. Bernstein and licensed to Nohla Therapeutics. The outcome of the project could impact the value of Dr. Bernstein's financial interest in Nohla in terms of increased equity value and increased intellectual property payments.
Novel regulation of Notch-induced HSPC expansion
Project Narrative The Notch signaling pathway controls the development of blood cells, with the strength of the Notch signal determining which blood cells are formed. Our goal is to grow more blood precursor cells, which can be clinically administered, by inducing Notch signaling in stem cells otherwise insusceptible to Notch activation, but in a way that delivers an optimal Notch signal for precursor generation.�
Filed on July 18, 2017.
Tell us what you know about Irwin Bernstein's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Irwin Bernstein filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Irwin Bernstein | Fred Hutchinson Cancer Research Center | Conflict of Interest | Nohla Therapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.